Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -5.00 (-0.73%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Completion of DE-KA Acquisition

17 Feb 2021 14:08

RNS Number : 4670P
Volex PLC
17 February 2021
 

17 February 2021

Volex plc

("Volex" or the "Company")

 

Completion of DE-KA Acquisition

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, confirms that, further to the announcement of the proposed acquisition of De-Ka Elektroteknik Sanayi ve Ticaret Anonim Şirketi ("DE-KA") made on 12 November 2020 (the "Acquisition"), the Acquisition has been fully approved by the Turkish Competition Authority and 3,320,000 Ordinary Shares of 25 pence each in Volex (the "Consideration Shares") have been conditionally allotted to the sellers to satisfy the share element of the consideration payable pursuant to the Acquisition. Completion of the Acquisition ("Completion") shall take place automatically immediately following admission of the Consideration Shares to trading on AIM, which is expected to take place on or around 8.00am on 18 February 2021.

The cash consideration payable in respect of the Acquisition comprises an initial cash consideration of €37.0 million, a deferred cash consideration of €2.0 million payable in January 2022 and a deferred contingent cash consideration of up to €13.0 million, which may be payable within two years of Completion based on certain profit targets of DE-KA being met.

An additional €9.8 million is to be satisfied by the issue of the Consideration Shares to the sellers on Completion. The value of the Consideration Shares is based on Volex's share price of £2.63 on the date that the sale and purchase agreement was signed. The Consideration Shares are subject to a six-month lock-up.

In addition, Volex is pleased to confirm that Servatron, Inc ("Servatron") has achieved certain operating profit targets for the year ended 31 December 2020 set under the acquisition agreement entered into on 30 July 2019. The second tranche of deferred consideration shares are now due to the former owners, and current employees, of Servatron, comprising 1,481,239 Ordinary Shares of 25 pence each in Volex (the "Servatron Deferred Consideration Shares"). The Volex Board has therefore approved the issue of the Servatron Deferred Consideration Shares.

Application has been made to the London Stock Exchange for the admission of the 3,320,000 Consideration Shares in respect of DE-KA and 1,481,239 Servatron Deferred Consideration Shares in respect of Servatron to trading on AIM ("Admission"). Admission of the Consideration Shares and Servatron Deferred Consideration Shares is expected to take place on or around 8.00am on 18 February 2021.

The Company's total issued share capital following Admission will consist of 157,052,041 ordinary shares of 25 pence each with one voting right per share. The Company holds no ordinary shares in treasury. Therefore, following Admission, this figure of 157,052,041 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

Nat Rothschild, Executive Chairman of Volex, commented:

"DE-KA is a world-class business, and one of the two leading power cord producers in Europe. This, combined with its strong management team and impressive customer list, means it is a perfect fit with our existing business and accelerates our strategy of creating the most efficient and lowest cost global producer in the industry, providing an immediate and scalable European platform. I am delighted for our shareholders that we are completing the acquisition and look forward to working alongside the DE-KA team on the next exciting stage of Volex's development."

-ENDS-

For further information please contact: 

 

Volex plc +44 (0) 7747 488 785

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

 

Powerscourt - Media Enquiries +44 (0)20 7250 1446

James White

Jack Holden

 

N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496 3000

Shaun Dobson

Iqra Amin

 

HSBC Bank Plc - Joint Broker +44 (0)20 7991 8888

Simon Alexander

Joe Weaving

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQTRMITMTMBBRB
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.